CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
Drugmaker taps 1 million retail touchpoints, quick commerce and modern trade to expand ingredient-led skincare franchise
Subscribe To Our Newsletter & Stay Updated
